Wei et al. discovered that SNHG5 could inhibit the epithelial–mesenchymal transition (EMT) process in oesophageal cancer cells by downregulating the expression of metastasis-associated protein 2 (MTA2) [28]. Here, SNHG5 is linked to carcinoma of esophagus.